Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LENS

Presbia (LENS) Stock Price, News & Analysis

Presbia logo

About Presbia Stock (NASDAQ:LENS)

Advanced Chart

Key Stats

Today's Range
$26.80
$26.80
50-Day Range
$0.07
$0.32
52-Week Range
$0.23
$5.50
Volume
N/A
Average Volume
122,366 shs
Market Capitalization
$461.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.

Receive LENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Presbia and its competitors with MarketBeat's FREE daily newsletter.

LENS Stock News Headlines

Contact Lens King Coupons
Trump’s Bitcoin Reserve is No Accident…
For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.
Real and virtual images
Types of lens
Convex and concave lenses
See More Headlines

LENS Stock Analysis - Frequently Asked Questions

Presbia PLC (NASDAQ:LENS) issued its quarterly earnings data on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.07. The medical instruments supplier had revenue of $0.01 million for the quarter, compared to the consensus estimate of $0.04 million. Presbia had a negative net margin of 36,604.35% and a negative trailing twelve-month return on equity of 414.02%.

Presbia (LENS) raised $50 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,200,000 shares at a price of $11.00-$13.00 per share. Jefferies served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Presbia investors own include Ritter Pharmaceuticals (RTTR), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Bellatrix Exploration (BXE), Second Sight Medical Products (EYES), Lilis Energy (LLEX) and Marinus Pharmaceuticals (MRNS).

Company Calendar

Last Earnings
8/12/2016
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:LENS
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.41 million
Net Margins
-36,604.35%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20,000.00
Price / Sales
23,180.29
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
298.97

Miscellaneous

Free Float
N/A
Market Cap
$463.61 million
Optionable
Not Optionable
Beta
2.57
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:LENS) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners